Interestingly, jun copy number loss has clinical relevance for luminal breast cancer, as patients with jun copy number loss have worse prognoses and respond more poorly to hormonal therapies compared to patients with no jun copy number loss [71]. This evidence concerns the gene JUN and breast cancer.